Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.53554 | 58 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.52053 | 59 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.08737 | 46 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.47237 | 59 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.60261 | 61 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.97934 | 65 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.51538 | 56 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.52351 | 59 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.5874 | 60 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.37723 | 56 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.51237 | 58 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.29923 | 54 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.4608 | 57 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.59696 | 60 |